Lista de obras - Janice M Reichert - Dominio Público Uruguay

4th European Antibody Congress 2008: December 1-3, 2008, Geneva, Switzerland

artículo científico publicado en 2009

5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland

artículo científico publicado en 2010

6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland

artículo científico publicado en 2011

7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.

artículo científico publicado en 2012

7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, France.

artículo científico publicado en 2012

9th annual European Antibody Congress, November 11-13, 2013, Geneva, Switzerland

artículo científico publicado en 2014

A decade of the Fast Track programme

artículo científico publicado en 2008

Americas Antibody Congress: September 21-23, 2009, Washington, D.C.

artículo científico publicado en 2009

Anti-infective monoclonal antibodies: perils and promise of development

article

Antibodies to watch in 2010

artículo científico publicado en 2010

Antibodies to watch in 2013: Mid-year update

artículo científico publicado en 2013

Antibodies to watch in 2014

artículo científico publicado en 2014

Antibodies to watch in 2015

artículo científico publicado en 2015

Antibodies to watch in 2016.

artículo científico publicado en 2015

Antibodies to watch in 2017

artículo científico publicado en 2016

Antibodies to watch in 2019

scientific article published on 22 December 2018

Antibodies to watch in 2020

artículo científico publicado en 2020

Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.

artículo científico publicado en 2015

Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA

artículo científico publicado en 2016

Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.

artículo científico publicado en 2016

Antibody Engineering and Therapeutics Conference: The Annual Meeting of the Antibody Society, December 8–12, 2013, Huntington Beach, CA.

artículo científico publicado en 2013

Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.

artículo científico publicado en 2014

Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA

artículo científico publicado en 2014

Antibody-based therapeutics to watch in 2011 ⬇️

artículo científico publicado el 1 de enero de 2011

Antibody-drug conjugates: present and future

artículo científico publicado en 2014

Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry

artículo científico publicado en 2013

Bispecific antibodies and ADCs: Once and future kings?

artículo científico publicado en 2011

Bispecific antibodies: a mechanistic review of the pipeline

scientific article published on 01 August 2019

Clinical Approval Success Rates for Investigational Cancer Drugs

artículo científico publicado en 2013

Development trends for human monoclonal antibody therapeutics ⬇️

artículo científico publicado el 3 de septiembre de 2010

Development trends for monoclonal antibody cancer therapeutics.

artículo científico publicado en 2007

Development trends for new cancer therapeutics and vaccines.

artículo científico publicado en 2007

Development trends for therapeutic antibody fragments

artículo científico publicado en 2009

Editorial for PEDS special issue on antibodies

artículo científico publicado en 2010

European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK

artículo científico publicado en 2009

Global antibody development trends

artículo científico publicado en 2009

IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.

artículo científico publicado en 2011

IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.

artículo científico publicado en 2012

IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.

artículo científico publicado en 2012

Innovative antibody research and development (R&D) is the vanguard of a variety of science, technology, and medical fields that require substantial investment of both time and money

artículo científico publicado en 2009

Letter from the Editor

scientific article published on 27 May 2009

Letter from the Editor

Letter from the Editor: stratified medicine

artículo científico publicado en 2010

Marketed therapeutic antibodies compendium ⬇️

artículo científico publicado el 26 de abril de 2012

Marketing approval of mogamulizumab: a triumph for glyco-engineering

artículo científico publicado en 2012

Medicinal biotechnology products: big problems or big opportunities?

artículo científico publicado en 2001

Metrics for antibody therapeutics development ⬇️

artículo científico publicado el 1 de noviembre de 2010

Monoclonal antibodies in the clinic.

artículo científico publicado en 2001

Monoclonal antibody successes in the clinic

artículo científico publicado en 2005

New biopharmaceuticals in the USA: trends in development and marketing approvals 1995-1999.

artículo científico publicado en 2000

Next generation and biosimilar monoclonal antibodies: Essential considerations towards regulatory acceptance in Europe; February 3-4, 2011; Freiburg, Germany ⬇️

artículo científico publicado el 1 de mayo de 2011

Note of appreciation to reviewers

artículo científico publicado en 2016

Note of appreciation to reviewers

Progress at mAbs.

artículo científico publicado en 2010

Recombinant protein therapeutics--success rates, market trends and values to 2010.

artículo científico publicado en 2004

Second International Conference on Accelerating Biopharmaceutical Development: March 9-12, 2009, Coronado, CA USA.

artículo científico publicado en 2009

Second International Conference on Accelerating Biopharmaceutical Development: March 9-12, 2009, Coronado, CA, USA.

artículo científico publicado en 2009

The amazing, multipurpose antibody

artículo científico publicado en 2011

The future of antibodies as cancer drugs ⬇️

artículo científico publicado el 26 de abril de 2012

Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies

artículo científico publicado en 2011

Therapeutic cancer vaccines on trial

artículo científico publicado en 2002

Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France

artículo científico publicado en 2016

Trends in US approvals: new biopharmaceuticals and vaccines.

artículo científico publicado en 2006

Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections

article

Which are the antibodies to watch in 2012?

artículo científico publicado en 2012

Which are the antibodies to watch in 2013?

artículo científico publicado en 2012

World Bispecific Antibody Summit, September 27-28, 2011, Boston, MA.

artículo científico publicado en 2012

mAb therapeutic products and risk management

artículo científico publicado en 2010

mAbs’s communication networks ⬇️

artículo científico publicado el 1 de marzo de 2012

Lista de obras de Janice M Reichert

4th European Antibody Congress 2008: December 1-3, 2008, Geneva, Switzerland

5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland

6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland

7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.

7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, France.

9th annual European Antibody Congress, November 11-13, 2013, Geneva, Switzerland

A decade of the Fast Track programme

Americas Antibody Congress: September 21-23, 2009, Washington, D.C.

Anti-infective monoclonal antibodies: perils and promise of development

Antibodies to watch in 2010

Antibodies to watch in 2013: Mid-year update

Antibodies to watch in 2014

Antibodies to watch in 2015

Antibodies to watch in 2016.

Antibodies to watch in 2017

Antibodies to watch in 2019

Antibodies to watch in 2020

Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.

Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA

Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.

Antibody Engineering and Therapeutics Conference: The Annual Meeting of the Antibody Society, December 8–12, 2013, Huntington Beach, CA.

Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.

Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA

Antibody-based therapeutics to watch in 2011 ⬇️

Antibody-drug conjugates: present and future

Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry

Bispecific antibodies and ADCs: Once and future kings?

Bispecific antibodies: a mechanistic review of the pipeline

Clinical Approval Success Rates for Investigational Cancer Drugs

Development trends for human monoclonal antibody therapeutics ⬇️

Development trends for monoclonal antibody cancer therapeutics.

Development trends for new cancer therapeutics and vaccines.

Development trends for therapeutic antibody fragments

Editorial for PEDS special issue on antibodies

European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK

Global antibody development trends

IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.

IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.

IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.

Innovative antibody research and development (R&D) is the vanguard of a variety of science, technology, and medical fields that require substantial investment of both time and money

Letter from the Editor

Letter from the Editor

Letter from the Editor

Letter from the Editor: stratified medicine

Marketed therapeutic antibodies compendium ⬇️

Marketing approval of mogamulizumab: a triumph for glyco-engineering

Medicinal biotechnology products: big problems or big opportunities?

Metrics for antibody therapeutics development ⬇️

Monoclonal antibodies in the clinic.

Monoclonal antibody successes in the clinic

New biopharmaceuticals in the USA: trends in development and marketing approvals 1995-1999.

Next generation and biosimilar monoclonal antibodies: Essential considerations towards regulatory acceptance in Europe; February 3-4, 2011; Freiburg, Germany ⬇️

Note of appreciation to reviewers

Note of appreciation to reviewers

Progress at mAbs.

Recombinant protein therapeutics--success rates, market trends and values to 2010.

Second International Conference on Accelerating Biopharmaceutical Development: March 9-12, 2009, Coronado, CA USA.

Second International Conference on Accelerating Biopharmaceutical Development: March 9-12, 2009, Coronado, CA, USA.

The amazing, multipurpose antibody

The future of antibodies as cancer drugs ⬇️

Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies

Therapeutic cancer vaccines on trial

Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France

Trends in US approvals: new biopharmaceuticals and vaccines.

Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections

Which are the antibodies to watch in 2012?

Which are the antibodies to watch in 2013?

World Bispecific Antibody Summit, September 27-28, 2011, Boston, MA.

mAb therapeutic products and risk management

mAbs’s communication networks ⬇️